US Bancorp’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

US Bancorp’s Portfolio PNT Stock Details PNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-89	Closed	-$594	–	4187
2023 Q3	$594	Sell	89 -15,621	-99%	-$130K	﹤0.01%	3828
2023 Q2	$142K	Buy	+15,710	New	+$139K	﹤0.01%	2033

Other funds holding PNT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

US Bancorp's PNT Position: Q4 2023 in Review

US Bancorp sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 89 shares — an estimated $594 sold.

US Bancorp first reported a position in PNT in Q2 2023 and held it in 2 quarters. The position peaked at $142K in Q2 2023. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

US Bancorp reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
US Bancorp sold 89 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $594.
US Bancorp first reported a position in POINT Biopharma Global Inc. Common Stock in Q2 2023 and held it in 2 quarters.
US Bancorp's POINT Biopharma Global Inc. Common Stock position peaked at $142K in Q2 2023.
1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on US Bancorp's 13F filing for Q4 2023, filed 9 Feb 2024.